Table 1 Participant characteristics.

From: The utility of next generation sequencing targeted multigene panels in the Adult Neurogenetic Clinic at Tygerberg Hospital, South Africa

CATEGORY

DETAILS

 Total Participants

74

COMBINED FEMALE AND MALE AGE STATISTICS

 Age Range

18 to 75 years

 Median Age

36 years (IQR 25–53)

 AGE DISTRIBUTION

 18–19 years

6 (8.1%)

 20–29 years

23 (31.0%)

 30–39 years

14 (18.9%)

 40–49 years

5 (6.8%)

 50–59 years

19 (25.7%)

 60 and above

7 (9.5%)

ANCESTRY PROFILE

 African

7 (9.5%)

 Mixed Ancestry South African

18 (24.3%)

 Caucasian

44 (59.5%)

 Indian

5 (6.7%)

DIAGNOSTIC YIELD IN INDEX PARTICIPANTS (n = 43)

 Positive Pathogenic Result

17 (39.5%)

 Positive Carrier Status

7 (16.3%)

 Variant of Uncertain Significance (VUS)

12 (27.9%)

 Negative Result

7 (16.3%)

 FAMILY VARIANT TESTING (n = 31)

 Familial Carrier Status Screening

13 (41.9%)

 Familial Symptomatic Diagnostic Test

4 (12.9%)

 Familial Asymptomatic Predictive Test

11 (35.5%)

 Familial VUS Resolution

3 (9.7%)

 FAMILY VARIANT TEST OUTCOMES

Variant Detected (Carrier Screening)

Parent (4), Sibling (3)

 Variant Not Detected (Carrier Screening)

Offspring (2), Parent (3), Sibling (1)

 Variant Detected (Symptomatic Diagnostic Test)

Parent (1), Sibling (3)

 Variant Detected (Asymptomatic Predictive Test)

Offspring (1), Sibling (1)

 Variant Not Detected (Asymptomatic Predictive Test)

Offspring (4), Parent (2), Sibling (3)

 Variant Detected (VUS Resolution)

Parent (2)

 Variant Not Detected (VUS Resolution)

Offspring (1)

  1. Bold numbers indicate actual number, with percentage of total in brackets.